Alexandria, VA, USA – A study aiming to develop a Lipid nanoparticles (LNP) platform for treating oral squamous cell carcinoma (OSCC) utilizing p53 mRNA was presented at the 102 nd General Session of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback